Market Cap

Blueprint Medicines Corporation Market Capitalization:

$6.83 Billion

USD as of July 1, 2024

business Blueprint Medicines Corporation Company Profile

Blueprint Medicines Corporation Main Stock Listing

NASDAQ: BPMC

Market Capitalization History of Blueprint Medicines Corporation

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Blueprint Medicines Corporation market cap

Date Market Cap YoY Change
Jan. 1, 2024 $5.04 B 79.32%
Jan. 1, 2023 $2.81 B -39.21%
Jan. 1, 2022 $4.63 B -20.31%
Jan. 1, 2021 $5.81 B 52.48%
Jan. 1, 2020 $3.81 B -11.99%
Jan. 1, 2019 $4.33 B -8.34%
Jan. 1, 2018 $4.72 B 130.78%
Jan. 1, 2017 $2.05 B 116.79%
Jan. 1, 2016 $943.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Blueprint Medicines Corporation Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Blueprint Medicines Corporation has the following listings and related stock indices.


Stock: NASDAQ: BPMC

Stock: FSX: 2L9

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.